Advanced Search

 

Study ID Status Title Patient Level Data
201135 Completed 201135 : A Randomised, Double-blind, Multicenter, Parallel-group Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily with Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Subjects Stepped Down from a Maintenance Therapy with RELVAR® inhaler (FF/VI) 100/25 mcg Once-daily in Japanese Subjects Study Listed on ClinicalStudyDataRequest.com
201147 Completed 201147: a Phase IIIb, randomized, open-label study of the safety, efficacy, and tolerability of switching to a fixed-dose combination of abacavir/dolutegravir/ lamivudine from current antiretroviral regimen compared with continuation of the current antiretroviral regimen in HIV-1 infected adults who are virologically suppressed, The STRIIVING Study.
201152 Active not recruiting Indirect treatment comparisons of Ph3 combination studies for dabrafenib plus trametinib versus other treatments
201153 Completed Updated analyses adjusting for treatment crossover in Part C of a Phase 2 trial (BRF113220) of dabrafenib and trametinib combination therapy in patients with metastatic melanoma based on recent dataset (March 2013)
201159 Completed A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Effect of 12 weeks of Once-daily Dosing of the Oral Motilin Receptor Agonist Camicinal, on Gastroparesis Symptoms in Type 1 and 2 Diabetic Subjects with Gastroparesis
201167 Completed A Phase I, open label, parallel group, three period, fixed sequence crossover study to evaluate the effect of dolutegravir on metformin pharmacokinetics in healthy adult subjects
201182 Completed Meta-Analysis Plan for Study Number 201182, GSK1550188, SLE, Pregnancy Analysis
201186 Completed Utilization of Rosiglitazone in Triple Therapy and Insulin Combinations and Estimated Rates of Adverse Events in Rosiglitazone Recipients in Canada, 2011-2012
201188 Completed PGx7529: Exploratory Pharmacogenetic evaluation of Potential Modifiers of Duchenne Muscular Dystrophy patient response to Drisapersen
201211 Completed A 12 week, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy of Umeclidinium/Vilanterol 62.5/25mcg in Subjects with COPD Study Listed on ClinicalStudyDataRequest.com
201216 Active not recruiting PGx7521: Evaluation of validated HLA markers with DILI in lapatinib clinical trial EGF106903
201223 Active not recruiting Study 201223 - Interim Meta-analysis of BEL112233, BEL112234, BEL110751 and BEL110752
201224 Completed Meta-Analysis Plan for GSK1550188, 201224, Concomitant Medications Analysis
201233 Completed Meta-analysis of DB2116132 and DB2116133. An integrated review to evaluate dose reponse of GSK573719 administered once daily in subjects with COPD
201234 Completed Immunogenicity and safety study of GSK Biologicals’ quadrivalent influenza vaccine (GSK2282512A) compared to Fluzone® Quadrivalent in children 6 to 35 months of age
201235 Completed PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011
201240 Completed Waterpipe use in the Middle East and North Africa: analysis of the BREATHE study
201241 Completed COMORBIDITIES ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE MIDDLE EAST: ANALYSIS FROM THE BREATHE STUDY
201243 Completed Distribution of body mass index among subjects with chronic obstructive pulmonary disease in the Middle East and North Africa: data from the BREATHE study
201244 Completed A randomized, double-blinded study to evaluate the ability of an acne treatment product to produce visible improvements in acne lesions over a 5 day period of once-daily use
201246 Completed A Phase I, Randomised, Double-blind (sponsor open), Placebo-Controlled Single Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330811 in Healthy Subjects
201248 Completed An enabling study to compare the Inhalation Profiles of women in the third stage of labour to those of non-pregnant female volunteers and to explore whether there are any differences which could impact the delivery of an Inhaled medicinal product
201251 Completed Safety and immunogenicity study of GSK Biologicals’ Quadrivalent Influenza Candidate Vaccine (GSK23211381A) manufactured with a new process in adults and children
201275 Recruiting ALDREB Drug Use Investigation
201280 Active not recruiting Evidence synthesis to assess comparative efficacy of UMEC versus other treatments for COPD adult patients

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.